Tegaserod analytical method [Regulatives / Guidelines]

posted by Ayman Rabayah – Jordan, 2020-04-08 11:23 (120 d 03:39 ago) – Posting: # 21318
Views: 659

Hello colleagues
I hope you are in good health and conditions, and wish the the COVID-19 crisis come to end in all countries.
kindly we are developing an analytical method for Tegaserod in human plasma, if you have an experience with this product (6 mg dose), is the metabolite M29 need to be included to be detected and measured, and if an LLOQ of 50 pg/ml will be enough?

looking to hear your advises
Thank you

Complete thread:

 Admin contact
20,969 posts in 4,374 threads, 1,460 registered users;
online 20 (1 registered, 19 guests [including 16 identified bots]).
Forum time: Thursday 15:03 CEST (Europe/Vienna)

It is a good morning exercise for a research scientist
to discard a pet hypothesis every day before breakfast.
It keeps him young.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz